FDA Clearance Tracker · P120016
VASCADE VASCULAR CLOSURE SYSTEM
Last checked: Nov 20, 2026Latest source record: Jan 31, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jan 31, 2013
Approved
Time to decision
181 days
Received Aug 3, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P120016
- Device name
- VASCADE VASCULAR CLOSURE SYSTEM
- Applicant
- Cardiva Medical, Inc.
- Applicant location
- Santa Clara, CA
- Received
- Aug 3, 2012
- Decided
- Jan 31, 2013
- Decision
- Approved
- Supplements
- 40 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE VASCADE¿ VASCULAR CLOSURE SYSTEM (VCS). THIS DEVICE IS INDICATED FOR FEMORAL ARTERIAL ACCESS SITE CLOSURE WHILE REDUCING TIMES TO HEMOSTASIS AND AMBULATION IN PATIENTS WHO HAVEUNDERGONE DIAGNOSTIC OR INTERVENTIONAL ENDOVASCULAR PROCEDURES USING A 5F, 6F, OR 7F PROCEDURAL SHEATH. THE VASCADE VCS IS ALSO INDICATED TO REDUCE TIME TO DISCHARGE ELIGIBILITY IN PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC ENDOVASCULAR PROCEDURES USING A 5F, 6F, OR 7F PROCEDURAL SHEATH.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MGB. The earliest in FDA's data is P920004, decided Sep 29, 1995.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Cardiva Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- VASCADE MVP XL VVCS Model 800-1014XLPMA supplement
P120016-S039 · Decided Mar 27, 2026 · 178 days after receipt · Panel Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.